✦ LIBER ✦

Cost-Effectiveness of Denosumab Versus Zoledronic Acid in the Management of Skeletal Metastases Secondary to Breast Cancer

✍ Scribed by Sonya J. Snedecor; John A. Carter; Satyin Kaura; Marc F. Botteman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of Denosumab Compared

✍ Jipan Xie; Melissa Diener; Rachael Sorg; Eric Q. Wu; Madhav Namjoshi 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 544 KB

Zometa® (zoledronic acid) in patients wi

✍ A Wardley; N Davidson; P Barrett-Lee; A Hong; J Mansi; D Dodwell; R Murphy; T Ma 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 318 KB

PCN66 Cost-Effectiveness of Denosumab Ve

✍ M.F. Botteman; J.A. Carter; P. Fishman; D. Chandiwana; M. Bains; S.J. Snedecor 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Cost effectiveness of bisphosphonates in

✍ M. Botteman; V. Barghout; J. Stephens; J. Hayl; K. Quednau 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 35 KB

AOS13 Denosumab versus zoledronic acid f

✍ A.T. Stopeck; G. Richardson; S. Siena; A. Lipton; J. Brown; K. Fizazi; D. Henry; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 41 KB

PCN78 COST-EFFECTIVENESS ASSESSMENT OF Z

✍ MF Botteman; JFS Logman; S Kaura 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB